Svea Bank launches SEK 805m cash offer for Qliro at an 85% premium
The Swedish bank has agreed to buy stakes from Rite Ventures, Mandatum and Peter Lindell's Cidro Förvaltning, which triggers a mandatory bid for the payments company. Qliro's board has not yet taken a position.
Svea Bank has announced a public cash offer of SEK 23.50 per share for all shares in Qliro, the Stockholm-listed payments and checkout fintech, according to its offer announcement published at 08:00 CET on 9 November 2026. The offer values all 34.2 million Qliro shares at SEK 805 million and represents a premium of 85.04% to Qliro's closing price of SEK 12.70 on 6 November.
Svea Bank already holds 3.48% of Qliro and has signed conditional agreements to buy a further 38.82% from shareholders including Rite Ventures, Mandatum and Cidro Förvaltning (Peter Lindell). Because that would take it above three tenths of the votes, Swedish takeover law obliges it to bid for the rest. Breakit reported the bid on Monday morning.
How the deal is structured
Svea Bank first said on 6 November that it had agreed to buy about 10.2 million Qliro shares from Rite Ventures, Cidro Förvaltning and others. It has since added about 3.1 million shares from Mandatum Private Equity Partnership and Mandatum Life Insurance. Those so-called prior transactions were agreed at SEK 17.79 per share. Because the public offer is higher, the sellers will receive a top-up to SEK 23.50, so they are treated the same as other shareholders.
Once the prior transactions complete, Svea Bank would own 42.30% of Qliro. The bank has therefore structured the offer from the start under the mandatory bid rules. Completion depends only on regulatory approvals, not on a minimum acceptance level. Svea Bank says it expects to need clearance from the Swedish Financial Supervisory Authority, the Swedish Inspectorate of Strategic Products and the Swedish Competition Authority.
The offer is financed in full from cash on hand. The shares Svea Bank does not already hold or has not agreed to buy are valued at SEK 464 million. The offer document is expected around 18 December 2026, with an acceptance period from about 21 December 2026 to 25 February 2027 and settlement from 4 March 2027. If Svea Bank passes 90%, it intends to squeeze out remaining holders and seek a delisting from Nasdaq Stockholm.
What the buyer says
"Svea Bank and Qliro have long been leading players in the Nordic payment solutions market. Bringing Qliro's expertise to Svea Bank's existing operations creates opportunities to defend and strengthen the companies' combined market position," said Lennart Ågren, chief executive of Svea Bank. The bank says it has been interested in buying Qliro for some time and does not currently plan material changes to Qliro's employees, management or locations.
Qliro's board is still assessing
Qliro's board said it has appointed ABG Sundal Collier as financial adviser and Wigge & Partners Law as legal adviser, and asked PwC for an independent fairness opinion. It will assess the offer against Qliro's business plan and prospects as an independent listed company and has not yet reached a view. It advised shareholders to wait for its recommendation before deciding.
The size of the premium reflects how far Qliro's shares had fallen: the offer is also 56.98% above the three-month volume-weighted average price of SEK 14.97. Svea Bank conducted a limited due diligence review, and Qliro confirmed no inside information was shared.
What it means for the Nordic fintech market
Qliro listed on Nasdaq Stockholm in October 2020 and is supervised as a credit market company by the Swedish FSA. Svea Bank, a Swedish banking group with more than 2,000 employees across Europe, already offers invoicing, debt collection and e-commerce payment solutions. A combination would bring together two Swedish players in Nordic e-commerce payments, a market where scale and funding costs matter.
For fintech founders, the deal is another sign that listed European fintechs with weakening share prices can become targets for well-capitalised incumbents. It also shows how a block purchase from early backers can effectively decide a takeover: once Rite Ventures, Mandatum and Cidro agreed to sell, the bid became mandatory and was set to proceed regardless of acceptance levels. Earlier this month ANI Pharmaceuticals made a recommended offer for Egetis Therapeutics, another Stockholm-listed company to receive a cash bid this month.
Spotted an error? Email contact@europreneursmedia.com and we'll correct it. See our corrections policy and editorial standards.
